Abstract
In this study, the bibliometric study of cholinesterase inhibitors was used to find the trend of Alzheimer’s disease (AD) research and the order of drugs which was most tolerated or more effective in AD treatment. 4,982 articles and reviews from the Science Citation Index Expanded during 1993–2012 were analyzed. The main results were as follows: The publication of cholinesterase inhibitor research increased overall during 1993–2012. Chinese Academy of Science had most publications, University of California, San Diego and Hebrew University of Jerusalem won first place with the highest average citation per paper and the highest h-index respectively. Neurosciences, pharmacology and chemistry were “raising” subject categories in cholinesterase inhibitors research. With the comprehensive analysis of distribution and change of author keywords in two 10-year-time periods, it can be concluded as follows: (i) the order of drugs which was most tolerated or more effective in AD treatment might be donepezil, galantamine, rivastigmine, tacrine, memantine and huperzine A, and memantine attracted increasing interest recently and might be used more frequently now, especially for moderate to severe dementia. (ii) The pathogenesis of oxidative stress hypothesis attracted extensive attention. The interest to β-amyloid cascade hypothesis increased slightly but that of the cholinergic hypothesis decreased during the past decade. (iii) “Oxidative stress”, “β-amyloid”, “neuroprotection”, “memory” and “cognition” are the main orientations in the AD research in the future.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahmad-Reza, J., Farhad, G., Abdolhadi, N., Mohammadali, N., Gholamreza, H., Amirhossein, M., et al. (2013). Presentation of psoriatic arthritis in the literature: A twenty-year bibliometric evaluation. Rheumatology International, 33(2), 361–367. doi:10.1007/s00296-012-2428-y.
Alzheimer’s Association. (2009). Alzheimer’s disease facts and figures. Alzheimer’s & Dementia, 5(3), 234–270. doi:10.1016/j.jalz.2009.03.001.
Alzheimer’s Association. (2012). Alzheimer’s disease facts and figures. Alzheimer’s & Dementia, 8(2), 131–168. doi:10.1016/j.jalz.2012.02.001.
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011). Alzheimer’s disease. Lancet, 377(9770), 1019–1031. doi:10.1016/S0140-6736(10)61349-9.
Bartus, R. T., Dean, R. L., Pontecorvo, M. J., & Flicker, C. (1985). The cholinergic hypothesis: A historical overview, current perspective, and future directions. Annals of the New York Academy of Sciences, 444, 332–358.
Birks, J. (2006). Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database of Systematic Reviews, 25(1), CD005593. doi:10.1002/14651858.CD005593.
Cao, Y., Zhou, S. X., & Wang, G. B. (2013). A bibliometric analysis of global laparoscopy research trends during 1997–2011. Scientometrics, 96(3), 717–730. doi:10.1007/s11192-012-0942-z.
Chuang, K. Y., Huang, Y. L., & Ho, Y. S. (2007). A bibliometric and citation analysis of stroke-related research in Taiwan. Scientometrics, 72(2), 201–212. doi:10.1007/s11192-007-1721-0.
Clive, B., Julian, H., Tony, H., Robin, J., & Sue, Z. (2003). Ethics and dementia: Mapping the literature by bibliometric analysis. International Journal of Geriatric Psychiatry, 18(1), 41–54. doi:10.1002/gps.770.
Courtney, C., Farrell, D., Gray, R., Hills, R., Lynch, L., Sellwood, E., et al. (2004). Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): Randomised double-blind trial. Lancet, 363(9427), 2105–2115.
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., et al. (2005). Global prevalence of dementia: A delphi consensus study. Lancet, 366(9503), 2112–2117.
Hitzeman, N. (2006). Cholinesterase inhibitors for Alzheimer’s disease. American Family Physician, 74(5), 747–749.
Ho, Y. S., Nakazawa, K., Sato, S., Tamura, T., Kurishima, K., & Satoh, H. (2013). Cisplatin for small cell lung cancer: Associated publications in Science Citation Index Expanded. Oncology Letters, 5(2), 684–688. doi:10.3892/ol.2012.1029.
Keiser, J., & Utzinger, J. (2005). Trends in the core literature on tropical medicine: A bibliometric analysis from 1952–2002. Scientometrics, 62(3), 351–365.
Li, L. L., Ding, G. H., Feng, N., Wang, M. H., & Ho, Y. S. (2009). Global stem cell research trend: Bibliometric analysis as a tool for mapping of trends from 1991 to 2006. Scientometrics, 80(1), 39–58. doi:10.1007/s11192-008-1939-5.
Mao, N., Wang, M. H., & Ho, Y. S. (2010). A bibliometric study of the trend in articles related to risk assessment published in science citation index. Human and Ecological Risk Assessment, 16(4), 801–824. doi:10.1080/10807039.2010.501248.
McShane, R., Areosa Sastre, A., & Minakaran, N. (2005). Memantine for dementia. Cochrane Database of Systematic Reviews, 20(3), CD003154.
Mueen Ahmed, K. K., & Gupta, B. M. (2013). India’s contribution on antioxidants: A bibliometric analysis, 2001–10. Scientometrics, 94(2), 741–754. doi:10.1007/s11192-012-0700-2.
Parihar, M. S., & Hemnani, T. (2004). Alzheimer’s disease pathogenesis and therapeutic interventions. Journal of Clinical Neuroscience, 11(5), 456–467. doi:10.1016/j.jocn.2003.12.007.
Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978). Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. British Medical Journal, 2(6150), 1457–1459.
Pratico, D. (2008). Oxidative stress hypothesis in Alzheimer’s disease: A reappraisal. Trends in Pharmacological Sciences, 29(12), 609–615.
Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., Friedhoff, L. T., Albala, B., et al. (1998). A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease. Neurology, 50(1), 136–145.
Sakai, S., Yoshida, H., Hirai, Y., Asari, M., Takigami, H., Takahashi, S., et al. (2011). International comparative study of 3R and waste management policy developments. Journal of Material Cycles and Waste Management, 13(2), 86–102. doi:10.1007/s10163-011-0009-x.
Sonkusare, S. K., Kaul, C. L., & Ramarao, P. (2005). Dementia of Alzheimer’s disease and other neurodegenerative disorders-memantine, a new hope. Pharmacological Research, 51(1), 1–17.
Sorensen, A. A. (2009). Alzheimer’s disease research: Scientific productivity and impact of the top 100 investigators in the field. Journal of Alzheimer’s Disease, 16(3), 451–465. doi:10.3233/JAD-2009-1046.
Wang, L. H., Wang, Q. H., Zhang, X., Cai, W. W., & Sun, X. H. (2013). A bibliometric analysis of anaerobic digestion for methane research during the period 1994–2011. Journal of Material Cycles and Waste Management, 15(1), 1–8. doi:10.1007/s10163-012-0094-5.
Wen, H., & Huang, Y. (2012). Trends and performance of oxidative stress research from 1991 to 2010. Scientometrics, 91(1), 51–63. doi:10.1007/s11192-011-0535-2.
Youdim, M. B. H., & Buccafusco, J. J. (2005). Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. Trends in Pharmacological Sciences, 26(1), 27–35.
Zitt, M., & Bassecoulard, E. (1994). Development of a method for detection and trend analysis of research fronts built by lexical or cocitation analysis. Scientometrics, 30(1), 333–351.
Acknowledgments
This study was funded by Zhejiang Science and Technology Library (2012E60002-11). The authors would like to express their sincere appreciation to Professor Weiguo Shao, School of Foreign Languages, Taizhou University, for editorial assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, H., Wan, Y., Jiang, S. et al. Alzheimer’s disease research in the future: bibliometric analysis of cholinesterase inhibitors from 1993 to 2012. Scientometrics 98, 1865–1877 (2014). https://doi.org/10.1007/s11192-013-1132-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11192-013-1132-3